KKKarin Kunzi-Rapp

Karin Kunzi-Rapp

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karin Kunzi-Rapp has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Grundlagen der IPL-Technik

    by Rudolf Steiner, Karin Kunzi-Rapp

  • Topical Propranolol Therapy for Infantile Hemangiomas

    by Karin Kunzi‐Rapp

    Abstract:  The nonselective beta‐adrenergic receptor antagonist propranolol is an effective therapy for infantile hemangiomas. Systemic propranolol therapy shows a rapid therapeutic effect with good drug tolerability. We report on the efficacy of local application of propranolol ointment in superficial hemangiomas of the skin. In our outpatient department, 45 children with 65 hemangiomas were treated with 1% propranolol in a hydrophilic ointment topically applied twice a day. Before start of treatment and at each visit, clinical photographs were taken. If ultrasound did not confirm occult deeper components, children were included in the study. Treatment in the proliferative phase within the first 6 months of life (including seven preterm infants) induced regression in 59% and cessation of growth in 26% of the hemangiomas. No response or proliferation of subcutaneous components was observed in 15%. Clinically, no side effects caused by the beta‐receptor blocker were noticed. Treatment of two ulcerated hemangiomas of the perineal region twice using a flash lamp pulsed‐dye laser and propranolol ointment in the surrounding lesion led to healing of the ulcers in 3 and 6 weeks, respectively. In six patients, topical therapy was started between the ages of 7 and 33 months. Even in these hemangiomas, improvement was obvious after 2 or 3 months. Propranolol administered topically in 1% ointment could have a beneficial effect on superficial hemangiomas of the skin. The treatment was well tolerated without side effects even in preterm infants and in children with numerous or large lesions.


  • Intense Pulsed Light Technology

    by Karin Kunzi-Rapp, Rudolf Steiner

  • Minimally invasive skin rejuvenation with Erbium: YAG laser used in thermal mode

    by Karin Kunzi-Rapp, Christine C. Dierickx, Bernard Cambier, Michael Drosner

    Background and Objectives To evaluate the efficacy and safety of a thermal mode Erbium:YAG laser several in‐vivo morphological as well as clinical changes were monitored in a multi‐center investigation. Study Design/Materials and Methods An Erbium:YAG laser was used at a thermal mode with sub‐ablative fluences of 2.1 and 3.1 J/cm2 with parallel air cooling to treat either periorbital, perioral rhytides or patients with post‐traumatic or acne scars. Two treatments were applied 2 months apart, with follow‐up at 1, 3, 6, and 12 months post‐treatment. Photographs were taken before and at each follow‐up visit and evaluated by three blinded independent reviewers. Histology and immunohistochemistry for pro‐collagen expression were investigated. Optical coherence tomography (OCT) was performed before, and at 4, 14, and 28 days after single pass treatment with Erbium:YAG thermal pulses. Results The improvement of rhytides at 1–3 months follow‐up was graded as excellent in 19%, good in 19%, fair in 31%, and no improvement in 31%. At the 6‐ to 12‐month follow‐up, the improvement was excellent in 40%, good in 40%, fair in 20%, and no improvement in 0%. The improvement of scars at 3–6 months follow‐up was graded as excellent in 50%, good in 25%, fair in 25%, and no improvement in 0%. Intra‐ and post‐operative discomfort was described as mild by the patients. OCT, histological sections and immunohistochemistry demonstrated production of new collagen bundles. Conclusions Thermal Erbium:YAG pulses can induce collagen neogenesis, as proved by temperature elevation and morphological changes in the upper dermis. This leads clinically to visible and long lasting reduction of wrinkles and scars after applying multiple passes with minimal side‐effects.


  • Increased Blood Levels of Human S100 in Melanoma Chick Embryo Xenografts’ Circulation

    by Karin Kunzi‐Rapp, Peter Kaskel, Rudolf Steiner, Ralf Uwe Peter, Gertraud Krähn

    The chorioallantoic membrane (CAM) of the fertilized egg allows grafting of human melanomas for short‐term investigations and offers the opportunity to investigate the behavior of metastasizing cells and the release of S100β into peripheral blood. Tissue from one primary melanoma as well as cutaneous and subcutaneous metastases of 10 melanoma patients with elevated levels of S100 in the peripheral blood before surgery were transplanted onto the CAM of chick embryos at day 5/6 of development. Grafts were nourished by the host blood supply 2 days after transplantation. Histologically, 3 days after grafting, metastasizing melanoma cells could be found near the vessels of the host membrane, penetrating the endothelial layer and entering the blood system. Growth conditions remained stable for 6 days after transplantation. Blood samples were taken from a larger CAM vessel before collecting the xenografts 5 days after grafting. Measurement of human S100 in peripheral blood was performed in a blinded manner. No negative control showed elevated levels of human S100 protein. Samples deriving from melanoma xenografts contained highly elevated levels of S100 protein in 80% of cases. The data strongly support the concept of graft–host interaction concerning adherence of tumors and extravasation of human melanoma cells.


  • Characterization of the chick chorioallantoic membrane model as a short-term in vivo system for human skin

    by K. Kunzi-Rapp, Angelika Rück, Roland Kaufmann

    We report on the cultivation and characterization of human skin on the chorioallantoic membrane of chicken eggs with the aim of replacing animals in short-term investigations in dermatology. Adult human split-thickness skin was grafted onto the chorioallantoic membrane of 5-day chick embryos. Grafts and surrounding host tissue were examined daily by in vivo stereomicroscopy and in histological sections and were characterized using a panel of monoclonal antibodies. The skin grafts were completely incorporated into the chorioallantoic membrane 2 days after transplantation. A remarkable angiogenesis occurred towards the grafts. Skin tissues revascularized within 2 or 3 days by reperfusion of the existing graft vasculature. Anastomosis of host and graft blood vessels occurred and the transplanted skin was nourished by the host blood supply as indicated by nucleated chick erythrocytes in the skin vessels. The skin grafts on the chorioallantoic membrane preserved an almost entire human phenotype. Besides a fully differentiated human epidermis and dermis containing all the cellular and extracellular constituents such as skin immune cells, capillary vessels composed of human endothelial cells were enclosed by a basement membrane of human origin. The integrin expression pattern formed in human skin transplants 5 days after grafting was identical to that of human skin controls before grafting.